Navigation

Anoro Ellipta vs. Incruse Ellipta

Are Anoro Ellipta and Incruse Ellipta the Same Thing?

Anoro Ellipta (umeclidinium and vilanterol) Inhalation Powder and Incruse Ellipta (umeclidinium) Inhalation Powder are used for the long-term, once-daily, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.

Anoro Ellipta and Incruse Ellipta both contain an anticholinergic. Anoro Ellipta also contains a long acting beta-adrenoceptor agonist (LABA).

Side effects of Anoro Ellipta and Incruse Ellipta that are similar include sore throat, sinusitis, respiratory tract infection, constipation, muscle spasms/pain, chest pain or discomfort, cough, stomach/abdominal pain, and fast or irregular heartbeats.

Side effects of Anoro Ellipta that are different from Incruse Ellipta include diarrhea, pain in extremities, neck pain, indigestion, gastroesophageal reflux disease (GERD), vomiting, weakness, itching, rash, conjunctivitis, hypersensitivity reactions including anaphylaxis and hives, changes in taste, tremor, and anxiety.

Side effects of Incruse Ellipta that are different from Anoro Ellipta include stuffy or runny nose, joint pain, tooth pain, and bruising or dark areas of skin.

Both Anoro Ellipta and Incruse Ellipta may interact with other anticholinergic drugs.

Anoro Ellipta may also interact with monoamine oxidase inhibitors (MAOIs), antidepressants, beta-blockers, and diuretics (water pills).

What Are Possible Side Effects of Anoro Ellipta?

Common side effects of Anoro Ellipta include:

  • sore throat,
  • sinusitis,
  • respiratory tract infection,
  • constipation,
  • diarrhea,
  • pain in extremities,
  • muscle spasms,
  • neck pain,
  • chest pain or discomfort,
  • cough,
  • indigestion,
  • abdominal pain,
  • gastroesophageal reflux disease (GERD),
  • vomiting,
  • weakness,
  • irregular heart beats,
  • itching,
  • rash,
  • conjunctivitis,
  • palpitations,
  • hypersensitivity reactions including anaphylaxis and hives,
  • changes in taste,
  • tremor, and
  • anxiety.

What Are Possible Side Effects of Incruse Ellipta?

Common side effects of Incruse Ellipta include:

  • upper respiratory infection,
  • stuffy or runny nose,
  • cough,
  • sore throat,
  • joint pain,
  • muscle pain,
  • tooth pain,
  • stomach pain,
  • bruising or dark areas of skin,
  • chest pain,
  • fast or irregular heartbeat, and
  • constipation.

What is Anoro Ellipta?

Anoro Ellipta (umeclidinium and vilanterol) Inhalation Powder is a combination anticholinergic and long acting beta-adrenoceptor agonist (LABA) used for the long-term, once-daily, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.

What is Incruse Ellipta?

Incruse Ellipta (umeclidinium) Inhalation Powder is an anticholinergic drug used for the long-term, once-daily, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.

What Drugs Interact With Anoro Ellipta?

Anoro Ellipta may interact with monoamine oxidase inhibitors (MAOIs), antidepressants, beta blockers, diuretics, and other anticholinergic drugs. Tell your doctor all medications and supplements you use. During pregnancy, Anoro Ellipta should be used only if prescribed. Tell your doctor if you are pregnant before taking Anoro Ellipta or if you become pregnant during treatment. It is unknown if this drug passes into breast milk. Consult your doctor before breastfeeding.

What Drugs Interact With Incruse Ellipta?

Incruse Ellipta may interact with other anticholinergic drugs. Tell your doctor all medications and supplements you use. During pregnancy, Incruse Ellipta should be taken only if prescribed. It is unknown if this drug passes into breast milk. Consult your doctor before breastfeeding.

How Should Anoro Ellipta Be Taken?

Anoro Ellipta is administered as 1 inhalation dose once daily by the orally inhaled route only.

How Should Incruse Ellipta Be Taken?

Incruse Ellipta (umeclidinium 62.5 mcg) should be administered as 1 inhalation dose once daily by the orally inhaled route only. Incruse Ellipta may interact with other anticholinergic drugs. Tell your doctor all medications and supplements you use.

Disclaimer

All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).

Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.

Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.

The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.

As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.

Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.

If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.

You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.